Speaker Details

Christopher John Sayed, MD, FAAD

Christopher John Sayed, MD, FAAD

SESSIONS

S044 Hidradenitis Suppurativa/Acne Inversa (HS/AI): Current Medical and Surgical Management
Mar 9, 2025 • 1:00 PM - 4:00 PM • W304A
U097 In Office Surgical Techniques for the Treatment of Moderate to Severe Hidradenitis Suppurativa (HS)
Mar 10, 2025 • 7:30 AM - 8:30 AM • W207A

DISCLOSURES

AbbVie – Advisory Board(Fees), Investigator(Fees), Speaker(Fees); Alumis – Consultant(Fees); AstraZeneca – Consultant (1099 relationship)(Fees); ChemoCentryx – Investigator(Grants/Research Funding); Elasmogen – Consultant (1099 relationship)(Fees); Eli Lilly – Stockholder Public Company(Stock); Incyte – Consultant (1099 relationship)(Fees); Incyte Corporation – Investigator(Grants/Research Funding); InflaRx – Consultant(Fees), Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Fees); Navigator Medicines – Consultant (1099 relationship)(Fees); Novartis – Investigator(Fees), Speaker(Honoraria); Sandoz Pharmaceuticals AG – Consultant (1099 relationship)(Honoraria); Sanofi – Consultant (1099 relationship)(Fees); UCB – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding);